These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 10946861

  • 21. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.
    Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY.
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3559-65. PubMed ID: 16804038
    [Abstract] [Full Text] [Related]

  • 22. Short-term testosterone supplementation does not activate GH and IGF-I production in postmenopausal women.
    Soares-Welch C, Mielke KL, Bowers CY, Veldhuis JD.
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):32-8. PubMed ID: 15963058
    [Abstract] [Full Text] [Related]

  • 23. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women.
    Ovesen P, Vahl N, Fisker S, Veldhuis JD, Christiansen JS, Jørgensen JO.
    J Clin Endocrinol Metab; 1998 May; 83(5):1662-7. PubMed ID: 9589674
    [Abstract] [Full Text] [Related]

  • 24. Differential pulsatile secretagogue control of GH secretion in healthy men.
    Norman C, Miles J, Bowers CY, Veldhuis JD.
    Am J Physiol Regul Integr Comp Physiol; 2013 May 01; 304(9):R712-9. PubMed ID: 23485864
    [Abstract] [Full Text] [Related]

  • 25. Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men.
    Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD.
    Eur J Endocrinol; 1998 Jul 01; 139(1):59-71. PubMed ID: 9703380
    [Abstract] [Full Text] [Related]

  • 26. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
    Erickson D, Keenan DM, Farhy L, Mielke K, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2005 Mar 01; 90(3):1741-51. PubMed ID: 15613434
    [Abstract] [Full Text] [Related]

  • 27. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.
    Hartman ML, Farello G, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1992 Jun 01; 74(6):1378-84. PubMed ID: 1592884
    [Abstract] [Full Text] [Related]

  • 28. Short-term fasting suppresses leptin and (conversely) activates disorderly growth hormone secretion in midluteal phase women--a clinical research center study.
    Bergendahl M, Evans WS, Pastor C, Patel A, Iranmanesh A, Veldhuis JD.
    J Clin Endocrinol Metab; 1999 Mar 01; 84(3):883-94. PubMed ID: 10084566
    [Abstract] [Full Text] [Related]

  • 29. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD, Keenan DM, Bailey JN, Miles JM, Bowers CY.
    Eur J Endocrinol; 2009 Aug 01; 161(2):293-300. PubMed ID: 19458139
    [Abstract] [Full Text] [Related]

  • 30. Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.
    Erickson D, Keenan DM, Mielke K, Bradford K, Bowers CY, Miles JM, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 Sep 01; 89(9):4746-54. PubMed ID: 15356089
    [Abstract] [Full Text] [Related]

  • 31. Growth hormone/insulin-like growth factor-1 response to acute and chronic growth hormone-releasing peptide-2, growth hormone-releasing hormone 1-44NH2 and in combination in older men and women with decreased growth hormone secretion.
    Bowers CY, Granda-Ayala R.
    Endocrine; 2001 Feb 01; 14(1):79-86. PubMed ID: 11322505
    [Abstract] [Full Text] [Related]

  • 32. Activation of somatostatin-receptor subtype-2/-5 suppresses the mass, frequency, and irregularity of growth hormone (GH)-releasing peptide-2-stimulated GH secretion in men.
    Iranmanesh A, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2004 Sep 01; 89(9):4581-7. PubMed ID: 15356066
    [Abstract] [Full Text] [Related]

  • 33. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
    Catalina PF, Mallo F, Andrade MA, García-Mayor RV, Diéguez C.
    J Clin Endocrinol Metab; 1998 Oct 01; 83(10):3663-7. PubMed ID: 9768681
    [Abstract] [Full Text] [Related]

  • 34. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
    Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL.
    J Clin Endocrinol Metab; 1993 Dec 01; 77(6):1641-7. PubMed ID: 7903313
    [Abstract] [Full Text] [Related]

  • 35. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release.
    Friend K, Iranmanesh A, Login IS, Veldhuis JD.
    Eur J Endocrinol; 1997 Oct 01; 137(4):377-86. PubMed ID: 9368506
    [Abstract] [Full Text] [Related]

  • 36. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD.
    J Clin Endocrinol Metab; 2002 Feb 01; 87(2):825-34. PubMed ID: 11836328
    [Abstract] [Full Text] [Related]

  • 37. Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.
    Veldhuis JD, Keenan DM, Bailey JN, Adeniji A, Miles JM, Paulo R, Cosma M, Soares-Welch C.
    J Clin Endocrinol Metab; 2008 Nov 01; 93(11):4471-8. PubMed ID: 18728158
    [Abstract] [Full Text] [Related]

  • 38. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G, Wouters P, Carlsson L, Baxter RC, Bouillon R, Bowers CY.
    J Clin Endocrinol Metab; 1998 Sep 01; 83(9):3062-70. PubMed ID: 9745404
    [Abstract] [Full Text] [Related]

  • 39. Tripartite control of growth hormone secretion in women during controlled estradiol repletion.
    Veldhuis JD, Cosma M, Erickson D, Paulo R, Mielke K, Farhy LS, Bowers CY.
    J Clin Endocrinol Metab; 2007 Jun 01; 92(6):2336-45. PubMed ID: 17405836
    [Abstract] [Full Text] [Related]

  • 40. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
    DeBell WK, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1991 Jun 01; 72(6):1312-6. PubMed ID: 2026752
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.